Evelo Biosciences, Inc. (EVLO)
EVLO Stock Price Chart
Explore Evelo Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze EVLO price movements and trends.
EVLO Company Profile
Discover essential business fundamentals and corporate details for Evelo Biosciences, Inc. (EVLO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 May 2018
Employees
66.00
Website
https://www.evelobio.comCEO
Craig R. Jalbert CIRA
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
EVLO Financial Timeline
Browse a chronological timeline of Evelo Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 24 Nov 2025
Earnings released on 4 Jun 2025
Earnings released on 29 May 2025
Earnings released on 28 Mar 2025
Earnings released on 26 Dec 2024
Earnings released on 27 Sept 2024
Earnings released on 7 Jun 2024
Earnings released on 26 Jan 2024
Earnings released on 9 Nov 2023
EPS came in at -$0.66 surpassing the estimated -$1.34 by +50.75%.
Earnings released on 14 Aug 2023
EPS came in at -$3.55 surpassing the estimated -$4.33 by +18.01%.
Stock split effective on 30 Jun 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$4.60 falling short of the estimated -$0.16 by -2.77K%.
Earnings released on 16 Mar 2023
EPS came in at -$4.20 surpassing the estimated -$6.00 by +30.00%.
Earnings released on 14 Nov 2022
EPS came in at -$5.60 surpassing the estimated -$6.60 by +15.15%.
Earnings released on 11 Aug 2022
EPS came in at -$8.00 surpassing the estimated -$11.20 by +28.57%.
Earnings released on 12 May 2022
EPS came in at -$11.20 surpassing the estimated -$11.60 by +3.45%.
Earnings released on 24 Mar 2022
EPS came in at -$10.80 surpassing the estimated -$12.20 by +11.48%.
Earnings released on 28 Oct 2021
EPS came in at -$12.60 falling short of the estimated -$11.40 by -10.53%.
Earnings released on 29 Jul 2021
EPS came in at -$11.80 falling short of the estimated -$10.80 by -9.26%.
Earnings released on 29 Apr 2021
EPS came in at -$11.00 falling short of the estimated -$10.60 by -3.77%.
Earnings released on 9 Mar 2021
EPS came in at -$12.40 falling short of the estimated -$9.60 by -29.17%.
Earnings released on 29 Oct 2020
EPS came in at -$9.00 surpassing the estimated -$10.00 by +10.00%.
EVLO Stock Performance
Access detailed EVLO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.